Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. WuXi AppTec Co., Ltd.
  6. Summary
    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
07/28/2021 07/29/2021 07/30/2021 08/02/2021 08/03/2021 Date
152.8 155.98 150 152.8 158.88 Last
33885480 25471790 21261880 28553140 26365050 Volume
+5.67% +2.08% -3.83% +1.87% +3.98% Change
Estimated financial data (e)
Sales 2021 21 943 M 3 396 M 3 396 M
Net income 2021 4 245 M 657 M 657 M
Net cash position 2021 15 437 M 2 389 M 2 389 M
P/E ratio 2021 108x
Yield 2021 0,24%
Sales 2022 28 781 M 4 454 M 4 454 M
Net income 2022 5 461 M 845 M 845 M
Net cash position 2022 12 262 M 1 898 M 1 898 M
P/E ratio 2022 82,8x
Yield 2022 0,31%
Capitalization 465 B 71 929 M 72 027 M
EV / Sales 2021 20,5x
EV / Sales 2022 15,7x
Nbr of Employees 27 272
Free-Float 57,3%
More Financials
Company
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows: - laboratory services (65,7%): small molecules discovery services, bioanalytical services, medical devices safety testing... 
More about the company
Ratings of WuXi AppTec Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about WUXI APPTEC CO., LTD.
07/26WUXI APPTEC : Inside information - proposed disposal of a shares by a shareholde..
PU
07/16WUXI APPTEC : Expects Up To 55% Growth in H1 Profit
MT
07/15WuXi AppTec Co., Ltd. Provides Earnings Guidance for the Six Months Ended Jun..
CI
07/13Temasek's Net Portfolio Rose to US$283 Billion for Fiscal Year Ended March
DJ
07/06Chinese Pharma Stocks Drop on Proposed New Rules for Oncology Drug Trials
DJ
07/06China stocks end lower as healthcare, tech firms tumble
RE
07/06China stocks fall on healthcare slump; Hong Kong down
RE
06/16China stocks fall as Sino-West tensions hit risk appetite
RE
06/02China's Stemirna raises about $200 million to fund COVID-19 vaccine developme..
RE
05/28Megarobo Technology Co., Ltd. announced that it has received $65 million in f..
CI
05/26Engine Biosciences Pte. Ltd. announced that it has received SGD 57 million in..
CI
05/14WUXI APPTEC : Articles of association
PU
05/14WUXI APPTEC : (1) poll results of the 2020 annual general meeting, the first a s..
PU
05/13WuXi AppTec Co., Ltd. Approves the 2020 Profit Distribution Plan
CI
05/07WUXI APPTEC : Unlocking and trading of the initial grant of restricted a shares ..
PU
More news
News in other languages on WUXI APPTEC CO., LTD.
07/06UPDATE/MÄRKTE ASIEN/Richtungswechsel in Sydney nach RBA-Beschlüssen
2018Hong Kong parti pour être en tête du classement des IPO en 2018
2018Fosun Tourism (Club Med) lève 428 millions de dollars lors de son IPO à Hong ..
More news
Analyst Recommendations on WUXI APPTEC CO., LTD.
More recommendations
Chart WUXI APPTEC CO., LTD.
Duration : Period :
WuXi AppTec Co., Ltd. Technical Analysis Chart | 603259 | CNE1000031K4 | MarketScreener
Technical analysis trends WUXI APPTEC CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 158,88 CNY
Average target price 178,63 CNY
Spread / Average Target 12,4%
EPS Revisions
Managers and Directors
Ge Li Chairman, President & Co-Chief Executive Officer
Qing Yang Co-CEO, Executive Director & Executive VP
Ellis Chu Chief Financial Officer & Senior Vice President
Harry He Chairman-Supervisory Board
Frederick H. Hausheer Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
WUXI APPTEC CO., LTD.41.52%71 929
GILEAD SCIENCES, INC.17.32%87 579
BIONTECH SE331.56%84 970
REGENERON PHARMACEUTICALS19.46%60 737
VERTEX PHARMACEUTICALS-15.36%51 899
BEIGENE, LTD.32.15%31 737